Skip to headlines

SCIENCE

GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children

ScienceDailyThursday, September 24, 2026 at 3:15 AM

RedScroll Brief

GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
Image via ScienceDaily

Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies.

RedScroll Signal

Impact
High
Category
Science
Market relevance
None
Why it matters
Scientific signal separates durable discovery from noise — and often foreshadows policy and product. Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies.

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 diabetes may face an overlooked risk: nutritional deficiencies.

Why it matters

Scientific signal separates durable discovery from noise — and often foreshadows policy and product.

Background

ScienceDaily reported on this under science. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

  1. ScienceDaily published: GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children

  2. Story is in today’s RedScroll edition. Follow the original source for updates.

More on

Related stories

Source

ScienceDaily

Original reporting by ScienceDaily. RedScroll provides an extractive briefing only.